Hinge Health

HNGE on NYSE. Hinge Health sells joint and muscle care software to self-insured employers and their workers. Market value $1.5bn.

Watch this stockFree. We tell you when something changes.

Price checks use the past 12 months to September 2026. Quality checks use five annual reports, the latest for the year to December 2025.

Should I look at this?

Not a fit for our list right now

See Technology stocks that passed both tests

This is not advice. Check the numbers below.

Compare with another stock

Cash yield
past 12 months to September 2026
3.7%fair

For every $100 of what the whole company costs, it produced $3.67 of spare cash in the past 12 months. A savings account pays about $4.

Price to profit
past 12 months to September 2026
55.9×full

You pay 55.9 years of operating profit for the business. The average large US company costs around 18.

Return on capital
five annual reports to December 2025
n/a

The filings do not give us enough to work this out.

Quality score: not known. Price score: 31 of 100. Our list needs 70 on quality and 60 on price.

$105.78 a share, 252% above its 1-year low

Over the past year the price has ranged from $30.08 to $126.40.

Pays no dividend

Prices from Friday’s close (20 November).

Five years of cash, in billions

0.2
0.3
202512 monthsto Sep '26

Spare cash swings from quarter to quarter here: $315 million in the past 12 months, $165 million in the year to December 2025.

Revenue
$588m
Operating margin
-92.9%
Debt to equity
0.00
Shares outstanding
0.00bn

Health checks

  • Free cash flow positive1 of 1 years
  • Accounting looks honest (Beneish)Not enough data
  • Financial strength (Piotroski)Not enough data
  • Profit backed by cash (accruals)Not enough data
  • Debt0.00× equity
  • Revenue growth, five yearsUnknown

The quarter to September 2026

How the business did, compared with the same quarter a year earlier.

  • Sales: $235 million last quarter, up 52% on a year ago.
  • Profit: $57 million, after a loss of $2 million a year ago.
  • 10% more shares than a year ago. Each share owns a bit less of the company.
  • It has $212 million more cash than debt, down from $261 million a year ago.
Sales by quarter
Sales by quarter
Quarter toAmount
June 2025$139m
September 2025$154m
December 2025$171m
March 2026$182m
June 2026$213m
September 2026$235m
Profit by quarter
Profit by quarter
Quarter toAmount
June 2025-$576m
September 2025-$2m
December 2025$32m
March 2026$35m
June 2026$44m
September 2026$57m

From the company's quarterly reports to the SEC.

Dates

Next results (estimated)
n/a
Last annual report (10-K)
3 March 2026
Next quarterly (estimated, 10-Q)
8 February 2027

Who owns it

3 long-term investors we follow own it, up from 2 last quarter. 277 funds in all.

Jun '25
Dec '25
Jun '26
Largest holders overall

From 13F filings for the quarter ended 30 June 2026.

Big holders and activists

9 investors own more than 5%.

  • Daniel Antonio Perez
    Passive investor
    15.7%−12.5 pts
    Since 31 December 2025
  • Gabriel M.I. Mecklenburg
    Passive investor
    13.0%
    Since 30 June 2025
  • BlackRock, Inc.
    Passive investor
    5.5%
    Since 30 June 2026
  • at least 4.8%−0.8 pts
    (filed with 2 related holders)
    Since 30 September 2025
  • JANE STREET GROUP, LLC
    Passive investor
    at least 4.2%−1.4 pts
    (filed with 3 related holders)
    Since 31 December 2025
  • Qian Zhuang
    Passive investor
    at least 4.0%−5.8 pts
    (filed with 5 related holders)
    Since 30 June 2026
  • at least 3.5%−5.9 pts
    (filed with 5 related holders)
    Since 30 September 2026
  • Deer X & Co. Ltd.
    Passive investor
    at least 3.0%−5.3 pts
    (filed with 2 related holders)
    Since 30 June 2026
  • Atomico Advisors IV, Ltd.
    Passive investor
    at least 2.9%−2.2 pts
    (filed with 2 related holders)
    Since 17 April 2026
  • HANSAINVEST Hanseatische Investment-Limited Co
    Passive investor
    Sold down below 5%
    Since 31 March 2026
  • Sold down below 5%
    Since 31 December 2025
  • The Vanguard Group
    Passive investor
    Sold down below 5%
    Since 13 March 2026
  • Sold down below 5%
    Since 31 December 2025

From Schedule 13D and 13G filings: anyone owning more than 5% must file one.

What insiders did

No insider bought shares on the open market in the last 12 months. 6 sold $199m, $197m of it under preset trading plans.

  • Robinson Elliott
    Director
    Sold
    Date
    11 November 2026
    Shares
    0
    Price
    n/a
    Value
    $0
  • Mecklenburg Gabriel M.I.
    Director
    Sold
    under a preset trading plan
    Date
    11 November 2026
    Shares
    200,000
    Price
    $122.41
    Value
    $24m
  • Robinson Elliott
    Director
    Sold
    Date
    10 November 2026
    Shares
    0
    Price
    n/a
    Value
    $0
  • Budge James
    Chief Financial Officer
    Sold
    under a preset trading plan
    Date
    10 November 2026
    Shares
    35,907
    Price
    $121.62
    Value
    $4m
  • Robinson Elliott
    Director
    Sold
    Date
    9 November 2026
    Shares
    0
    Price
    n/a
    Value
    $0
  • Robinson Elliott
    Director
    Sold
    Date
    5 November 2026
    Shares
    0
    Price
    n/a
    Value
    $0
  • Robinson Elliott
    Director
    Sold
    Date
    4 November 2026
    Shares
    0
    Price
    n/a
    Value
    $0
  • Mecklenburg Gabriel M.I.
    Director
    Sold
    under a preset trading plan
    Date
    12 October 2026
    Shares
    200,000
    Price
    $103.13
    Value
    $21m
  • Budge James
    Chief Financial Officer
    Sold
    under a preset trading plan
    Date
    12 October 2026
    Shares
    47,720
    Price
    $103.13
    Value
    $5m
  • Perez Daniel Antonio
    CEO & Co-Founder, Director
    Sold
    under a preset trading plan
    Date
    6 October 2026
    Shares
    4,100
    Price
    $100.20
    Value
    $410,811

From Form 4 filings: insiders must report trades in their own company's shares within two days.

Warning signs in its filings

Problems the company itself reported to the SEC, in its own words.

None of the warning signs we check for were found.

We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.

We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 3 Mar 2026, plus the 10-Q filed 9 Nov 2026 and 7 later 8-Ks.

A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.

What could go wrong

  • It isn't cheap on profits: 55.9× operating profit.

Whether the price already reflects the risks is what the deep dive is for.

The deep dive

Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.

  • What the business is worth, as a range, and the margin of safety at today’s price
  • Prices to start buying, buy, and buy hard
  • The three things that would make this a mistake
  • Every number footnoted to the filing it came from
Create a free account to run it

Your first deep dive is free.

What a finished deep dive looks like

Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.